Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis

Journal of Neurology

Volumn 260, Issue 10, 2013, Pages 2458-2471

  Vrenken, H ^a   Jenkinson, M ^b   Horsfield, M A ^c   Battaglini, M ^d   Van Schijndel, R A ^a   Rostrup, E ^e,f   Geurts, J J G ^a   Fisher, E ^g   Zijdenbos, A ^h   Ashburner, J ⁱ   Miller, D H ^j   Filippi, M ^k   Fazekas, F ^l   Rovaris, M ^m   Rovira, A ⁿ   Barkhof, F ^a   De Stefano, N ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Mental Health Services CPH   (Denmark)

^g LERNER RESEARCH INSTITUTE   (United States)

^h INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

ⁱ WELLCOME TRUST CENTRE FOR NEUROIMAGING   (United Kingdom)

^j University College London   (United Kingdom)

^k VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^l MEDICAL UNIVERSITY OF GRAZ   (Austria)

^m IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

more..

Author keywords

Brain atrophy; Image analysis; Magnetic resonance imaging; Multiple sclerosis; White matter lesions

Indexed keywords

ACCURACY; BRAIN ATROPHY; BRAIN DAMAGE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS;

ATROPHY; BRAIN; HUMANS; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MULTIPLE SCLEROSIS; NEUROIMAGING;

EID: 84886100580     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6762-5     Document Type: Review

References (101)

1. Filippi M, Rocca MA, de Stefano N, Enzinger C, Fisher E, Horsfield MA, Inglese M, Pelletier D, Comi G (2011) Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 68:1514-1520
2. Filippi M, Rocca MA, Benedict RH, DeLuca J, Geurts JJ, Rombouts SA, Ron M, Comi G (2010) The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75:2121-2128
3. Barkhof F, Calabresi PA, Miller DH, Reingold SC (2009) Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 5:256-266
4. Barkhof F, Simon JH, Fazekas F, Rovaris M, Kappos L, de Stefano N, Polman CH, Petkau J, Radue EW, Sormani MP, Li DK, O'Connor P, Montalban X, Miller DH, Filippi M (2012) MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat Rev Neurol 8:13-21
5. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, Gass A, Huerga E, Moraal B, Pareto D, Rocca MA, Wattjes MP, Yousry TA, Uitdehaag BM, Barkhof F (2011) Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76:418-424
6. Durand-Dubief F, Belaroussi B, Armspach JP, Dufour M, Roggerone S, Vukusics S, Hannoun S, Sappey-Marinier D, Confavreux C, Cotton F (2012) Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques. AJNR Am J Neuroradiol 33(10):1918-1924. doi: 10.3174/ajnr.A3107
7. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R (2005) Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64:1704-1711
8. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676-1695
9. Derakhshan M, Caramanos Z, Giacomini PS, Narayanan S, Maranzano J, Francis SJ, Arnold DL, Collins DL (2010) Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. Neuroimage 52:1261-1267
10. Filippi M, Rocca MA, Barkhof F, Bruck W, Chen JT, Comi G, DeLuca G, de Stefano N, Erickson BJ, Evangelou N, Fazekas F, Geurts JJ, Lucchinetti C, Miller DH, Pelletier D, Popescu BF, Lassmann H (2012) Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 11:349-360
11. Filippi M, Horsfield MA, Ader HJ, Barkhof F, Bruzzi P, Evans A, Frank JA, Grossman RI, McFarland HF, Molyneux P, Paty DW, Simon J, Tofts PS, Wolinsky JS, Miller DH (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43:499-506
12. Gedamu EL, Gedamu A (2012) Subject movement during multislice interleaved MR acquisitions: prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis. J Magn Reson Imaging 36:332-343
13. Moraal B, Roosendaal SD, Pouwels PJ, Vrenken H, van Schijndel RA, Meier DS, Guttmann CR, Geurts JJ, Barkhof F (2008) Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis. Eur Radiol 18:2311-2320
14. Barkhof F, Pouwels PJ, Wattjes MP (2011) The Holy Grail in diagnostic neuroradiology: 3T or 3D? Eur Radiol 21:449-456
15. Mikol DD, Barkhof F, Chang P, Coyle PK, Jeffery DR, Schwid SR, Stubinski B, Uitdehaag BM (2008) Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in relapsing MS disease [REGARD] study): a multicentre, randomised, parallel, open-label trial. Lancet Neurol 7:903-914
16. Radue EW, O'Connor P, Polman CH, Hohlfeld R, Calabresi P, Selmaj K, Mueller-Lenke N, Agoropoulou C, Holdbrook F, de Vera A, Zhang-Auberson L, Francis G, Burtin P, Kappos L (2012) Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis. Arch Neurol 1-11. doi: 10.1001/archneurol.2012.1051
17. Bagnato F, Butman JA, Gupta S, Calabrese M, Pezawas L, Ohayon JM, Tovar-Moll F, Riva M, Cao MM, Talagala SL, McFarland HF (2006) In vivo detection of cortical plaques by MR imaging in patients with multiple sclerosis. AJNR Am J Neuroradiol 27:2161-2167
18. Bagnato F, Yao B, Cantor F, Merkle H, Condon E, Montequin M, Moore S, Quezado M, Tkaczyk D, McFarland H (2009) Multisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging study. J Neurol Sci 282:80-85
19. de Graaf WL, Zwanenburg JJ, Visser F, Wattjes MP, Pouwels PJ, Geurts JJ, Polman CH, Barkhof F, Luijten PR, Castelijns JA (2012) Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR. Eur Radiol 22:221-231
20. Mike A, Glanz BI, Hildenbrand P, Meier D, Bolden K, Liguori M, Dell'oglio E, Healy BC, Bakshi R, Guttmann CR (2011) Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging. AJNR Am J Neuroradiol 32:515-521
21. Simon B, Schmidt S, Lukas C, Gieseke J, Traber F, Knol DL, Willinek WA, Geurts JJ, Schild HH, Barkhof F, Wattjes MP (2010) Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 20:1675-1683
22. Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA (2007) Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 28:1645-1649
23. Sethi V, Yousry TA, Muhlert N, Ron M, Golay X, Wheeler-Kingshott C, Miller DH, Chard DT (2012) Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 83:877-882
24. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532-544
25. Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, de Stefano N (2008) Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch Neurol 65:236-243
26. Sepulcre J, Masdeu JC, Sastre-Garriga J, Goni J, Velez-de-Mendizabal N, Duque B, Pastor MA, Bejarano B, Villoslada P (2008) Mapping the brain pathways of declarative verbal memory: evidence from white matter lesions in the living human brain. Neuroimage 42:1237-1243
27. Sepulcre J, Masdeu JC, Pastor MA, Goni J, Barbosa C, Bejarano B, Villoslada P (2009) Brain pathways of verbal working memory: a lesion-function correlation study. Neuroimage 47:773-778
28. Vellinga MM, Geurts JJ, Rostrup E, Uitdehaag BM, Polman CH, Barkhof F, Vrenken H (2009) Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging 29:768-773
29. Kincses ZT, Ropele S, Jenkinson M, Khalil M, Petrovic K, Loitfelder M, Langkammer C, Aspeck E, Wallner-Blazek M, Fuchs S, Jehna M, Schmidt R, Vecsei L, Fazekas F, Enzinger C (2011) Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler 17:681-689
30. Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ (2010) Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis. Hum Brain Mapp 31:1542-1555
31. Filli L, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Sprenger T, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K (2012) Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 18(11):1577-1584. doi: 10.1177/1352458512442756
32. Moraal B, Wattjes MP, Geurts JJ, Knol DL, van Schijndel RA, Pouwels PJ, Vrenken H, Barkhof F (2010) Improved detection of active multiple sclerosis lesions: 3D subtraction imaging. Radiology 255:154-163
33. Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O (2009) Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 30:2852-2861
34. Henry RG, Shieh M, Amirbekian B, Chung S, Okuda DT, Pelletier D (2009) Connecting white matter injury and thalamic atrophy in clinically isolated syndromes. J Neurol Sci 282:61-66
35. Zhuo J, Gullapalli RP (2006) AAPM/RSNA physics tutorial for residents: MR artifacts, safety, and quality control. Radiographics 26:275-297
36. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839-851
37. Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45-57
38. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17:87-97
39. Caramanos Z, Fonov VS, Francis SJ, Narayanan S, Pike GB, Collins DL, Arnold DL (2010) Gradient distortions in MRI: characterizing and correcting for their effects on SIENA-generated measures of brain volume change. Neuroimage 49:1601-1611
40. Takao H, Abe O, Hayashi N, Kabasawa H, Ohtomo K (2010) Effects of gradient non-linearity correction and intensity non-uniformity correction in longitudinal studies using structural image evaluation using normalization of atrophy (SIENA). J Magn Reson Imaging 32:489-492
41. Jovicich J, Czanner S, Greve D, Haley E, van der KA, Gollub R, Kennedy D, Schmitt F, Brown G, Macfall J, Fischl B, Dale A (2006) Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 30:436-443
42. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, de Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479-489
43. Battaglini M, Jenkinson M, de Stefano N (2012) Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 33(9):2062-2071. doi: 10.1002/hbm.21344
44. Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M (2012) The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis. AJNR Am J Neuroradiol 33(8):1579-1585. doi: 10.3174/ajnr.A3083
45. Chard DT, Jackson JS, Miller DH, Wheeler-Kingshott CA (2010) Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 32:223-228
46. Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J (2012) The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp 33(12):2802-2814. doi: 10.1002/hbm.21402
47. Nakamura K, Fisher E (2009) Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients. Neuroimage 44:769-776
48. Sdika M, Pelletier D (2009) Nonrigid registration of multiple sclerosis brain images using lesion inpainting for morphometry or lesion mapping. Hum Brain Mapp 30:1060-1067
49. Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL (2010) A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage 49:1524-1535
50. Nakamura K, Fox R, Fisher E (2011) CLADA: cortical longitudinal atrophy detection algorithm. Neuroimage 54:278-289
51. Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012) Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61:1402-1418
52. Duan Y, Hildenbrand PG, Sampat MP, Tate DF, Csapo I, Moraal B, Bakshi R, Barkhof F, Meier DS, Guttmann CR (2008) Segmentation of subtraction images for the measurement of lesion change in multiple sclerosis. AJNR Am J Neuroradiol 29:340-346
53. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22:1060-1075
54. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-155
55. Crinion J, Ashburner J, Leff A, Brett M, Price C, Friston K (2007) Spatial normalization of lesioned brains: performance evaluation and impact on fMRI analyses. Neuroimage 37:866-875
56. Jasperse B, Valsasina P, Neacsu V, Knol DL, de Stefano N, Enzinger C, Smith SM, Ropele S, Korteweg T, Giorgio A, Anderson V, Polman CH, Filippi M, Miller DH, Rovaris M, Barkhof F, Vrenken H (2007) Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually edited SIENA and SIENAX. J Magn Reson Imaging 26:881-885
57. Popescu V, Battaglini M, Hoogstrate WS, Verfaillie SC, Sluimer IC, van Schijndel RA, van Dijk BW, Cover KS, Knol DL, Jenkinson M, Barkhof F, de Stefano N, Vrenken H (2012) Optimizing parameter choice for FSL-brain extraction tool (BET) on 3D T1 images in multiple sclerosis. Neuroimage 61:1484-1494
58. Mortazavi D, Kouzani AZ, Soltanian-Zadeh H (2012) Segmentation of multiple sclerosis lesions in MR images: a review. Neuroradiology 54:299-320
59. Goldberg-Zimring D, Achiron A, Miron S, Faibel M, Azhari H (1998) Automated detection and characterization of multiple sclerosis lesions in brain MR images. Magn Reson Imaging 16:311-318
60. Hojjatoleslami SA, Kruggel F, von Cramon DY (1999) Segmentation of white matter lesions from volumetric MR images. In: Proceedings on Medical image computing and computer-assisted intervention, Miccai'99, 1999, 1679: 52-61
61. Pachai C, Zhu YM, Grimaud J, Hermier M, Dromigny-Badin A, Boudraa A, Gimenez G, Confavreux C, Froment JC (1998) A pyramidal approach for automatic segmentation of multiple sclerosis lesions in brain MRI. Comput Med Imaging Graph 22:399-408
62. Khayati R, Vafadust M, Towhidkhah F, Nabavi M (2008) Fully automatic segmentation of multiple sclerosis lesions in brain MR FLAIR images using adaptive mixtures method and Markov random field model. Comput Biol Med 38:379-390
63. Freifeld O, Greenspan H, Goldberger J (2009) Multiple sclerosis lesion detection using constrained GMM and curve evolution. Int J Biomed Imaging 2009:715124
64. Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J (2004) Probabilistic segmentation of white matter lesions in MR imaging. Neuroimage 21:1037-1044
65. Anbeek P, Vincken KL, van Osch MJ, Bisschops RH, van der Grond J (2004) Automatic segmentation of different-sized white matter lesions by voxel probability estimation. Med Image Anal 8:205-215
66. Mohamed FB, Vinitski S, Gonzalez CF, Faro SH, Lublin FA, Knobler R, Gutierrez JE (2001) Increased differentiation of intracranial white matter lesions by multispectral 3D-tissue segmentation: preliminary results. Magn Reson Imaging 19:207-218
67. Horsfield MA, Bakshi R, Rovaris M, Rocca MA, Dandamudi VS, Valsasina P, Judica E, Lucchini F, Guttmann CR, Sormani MP, Filippi M (2007) Incorporating domain knowledge into the fuzzy connectedness framework: application to brain lesion volume estimation in multiple sclerosis. IEEE Trans Med Imaging 26:1670-1680
68. Udupa JK, Wei L, Samarasekera S, Miki Y, van Buchem MA, Grossman RI (1997) Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging 16:598-609
69. van Leemput K, Maes F, Vandermeulen D, Colchester A, Suetens P (2001) Automated segmentation of multiple sclerosis lesions by model outlier detection. IEEE Trans Med Imaging 20:677-688
70. Lao Z, Shen D, Liu D, Jawad AF, Melhem ER, Launer LJ, Bryan RN, Davatzikos C (2008) Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol 15:300-313
71. Zijdenbos AP, Forghani R, Evans AC (2002) Automatic pipeline analysis of 3D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans Med Imaging 21:1280-1291
72. Molyneux PD, Wang L, Lai M, J G, Tofts PS, Moseley IF, Miller DH (1998) Quantitative techniques for lesion load measurement in multiple sclerosis: an assessment of the global threshold technique after non uniformity and histogram matching corrections. Eur J Neurol 5:55-60
73. Wang L, Lai HM, Barker GJ, Miller DH, Tofts PS (1998) Correction for variations in MRI scanner sensitivity in brain studies with histogram matching. Magn Reson Med 39:322-327
74. Wicks DA, Tofts PS, Miller DH, du Boulay GH, Feinstein A, Sacares RP, Harvey I, Brenner R, McDonald WI (1992) Volume measurement of multiple sclerosis lesions with magnetic resonance images. A preliminary study. Neuroradiology 34:475-479
75. Grimaud J, Lai M, Thorpe J, Adeleine P, Wang L, Barker GJ, Plummer DL, Tofts PS, McDonald WI, Miller DH (1996) Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 14:495-505
76. Molyneux PD, Tofts PS, Fletcher A, Gunn B, Robinson P, Gallagher H, Moseley IF, Barker GJ, Miller DH (1998) Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques. J Neurol Neurosurg Psychiatry 65:42-47
77. Gawne-Cain ML, O'Riordan JI, Coles A, Newell B, Thompson AJ, Miller DH (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry 64:197-203
78. Llado X, Ganiler O, Oliver A, Marti R, Freixenet J, Valls L, Vilanova JC, Ramio-Torrenta L, Rovira A (2012) Automated detection of multiple sclerosis lesions in serial brain MRI. Neuroradiology 54:787-807
79. Moraal B, Meier DS, Poppe PA, Geurts JJ, Vrenken H, Jonker WM, Knol DL, van Schijndel RA, Pouwels PJ, Pohl C, Bauer L, Sandbrink R, Guttmann CR, Barkhof F (2009) Subtraction MR images in a multiple sclerosis multicenter clinical trial setting. Radiology 250:506-514
80. Moraal B, van den Elskamp I, Knol DL, Uitdehaag BM, Geurts JJ, Vrenken H, van Schijndel RA, Meier DS, Guttmann CR (2010) Long-interval T2-weighted subtraction magnetic resonance imaging: a powerful new outcome measure in multiple sclerosis trials. Ann Neurol 67:667-675
81. Ait-Ali LS, Prima S, Hellier P, Carsin B, Edan G, Barillot C (2005) STREM: A robust multidimensional parametric method to segment MS lesions in MRI. In: Proceedings on medical image computing and computer-assisted intervention-Miccai 2005, Pt 1 3749:409-416
82. Gerig G, Welti D, Guttmann CR, Colchester AC, Szekely G (2000) Exploring the discrimination power of the time domain for segmentation and characterization of active lesions in serial MR data. Med Image Anal 4:31-42
83. Rey D, Subsol G, Delingette H, Ayache N (2002) Automatic detection and segmentation of evolving processes in 3D medical images: application to multiple sclerosis. Med Image Anal 6:163-179
84. Thirion JP, Calmon G (1999) Deformation analysis to detect and quantify active lesions in three-dimensional medical image sequences. IEEE Trans Med Imaging 18:429-441
85. Pieperhoff P, Sudmeyer M, Homke L, Zilles K, Schnitzler A, Amunts K (2008) Detection of structural changes of the human brain in longitudinally acquired MR images by deformation field morphometry: methodological analysis, validation and application. Neuroimage 43:269-287
86. Giorgio A, Battaglini M, Smith SM, de Stefano N (2008) Brain atrophy assessment in multiple sclerosis: importance and limitations. Neuroimaging Clin N Am 18:675-686 xi
87. Kezele IB, Chen JT, Arnold DL, Collins DL (2007) The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis. Mult Scler 13:809-813
88. Freeborough PA, Fox NC (1997) The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 16:623-629
89. Smith SM, Rao A, de Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC (2007) Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI. SIENA and SIENAX. Neuroimage 36:1200-1206
90. Anderson VM, Bartlett JW, Fox NC, Fisniku L, Miller DH (2007) Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates. J Neurol 254:1588-1594
91. Camara O, Schnabel JA, Ridgway GR, Crum WR, Douiri A, Scahill RI, Hill DL, Fox NC (2008) Accuracy assessment of global and local atrophy measurement techniques with realistic simulated longitudinal Alzheimer's disease images. Neuroimage 42:696-709
92. Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, de Stefano N (2009) Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. J Neurol Sci 282:55-60
93. Takao H, Hayashi N, Ohtomo K (2011) Effect of scanner in longitudinal studies of brain volume changes. J Magn Reson Imaging 34:438-444
94. Bendfeldt K, Hofstetter L, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Kappos L, Gass A, Nichols TE, Barkhof F, Vrenken H, Roosendaal SD, Geurts JJ, Radue EW, Borgwardt SJ (2012) Longitudinal gray matter changes in multiple sclerosis-differential scanner and overall disease-related effects. Hum Brain Mapp 33:1225-1245
95. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, Evans AC (1998) Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 17:463-468
96. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell L, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW (2008) The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27:685-691
97. Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ (2012) The Alzheimer's disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement 8:S1-68
98. Cover KS, van Schijndel RA, van Dijk BW, Redolfi A, Knol DL, Frisoni GB, Barkhof F, Vrenken H, neuGRID, Alzheimer's Disease Neuroimaging Initiative (2011) Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Res 193:182-190
99. Marcus DS, Wang TH, Parker J, Csernansky JG, Morris JC, Buckner RL (2007) Open access series of imaging studies (OASIS): cross-sectional MRI data in young, middle aged, non demented, and demented older adults. J Cogn Neurosci 19:1498-1507
100. Filippi M, Horsfield MA, Bressi S, Martinelli V, Baratti C, Reganati P, Campi A, Miller DH, Comi G (1995) Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 118(Pt 6):1593-1600
101. Filippi M, Rovaris M, Sormani MP, Horsfield MA, Rocca MA, Capra R, Prandini F, Comi G (1998) Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. AJNR Am J Neuroradiol 19:685-687